Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

6.56USD
20 Apr 2018
Change (% chg)

-- (--)
Prev Close
$6.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
183,253
52-wk High
$9.69
52-wk Low
$2.28

Latest Key Developments (Source: Significant Developments)

Pieris Pharma Doses First Subjects In Phase I Study Of PRS-060
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Astrazeneca Plc ::PIERIS PHARMACEUTICALS-DOSED FIRST SUBJECTS IN PHASE I STUDY OF PRS-060, TRIGGERING $12.5 MILLION MILESTONE PAYMENT FROM ASTRAZENECA TO CO-SEC FILING.  Full Article

Pieris Pharma Received Clearance to Initiate Its First-In-Human Study In Australia For PRS-060/AZD1402
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Pieris Pharmaceuticals Inc ::PIERIS PHARMACEUTICALS - RECEIVED ETHICS AND REGULATORY CLEARANCE TO INITIATE ITS FIRST-IN-HUMAN STUDY IN AUSTRALIA FOR PRS-060/AZD1402.PIERIS PHARMACEUTICAL - THE PHASE 1 STUDY IS BEING DEVELOPED AS PART OF PIERIS' STRATEGIC ALLIANCE WITH ASTRAZENECA.PIERIS PHARMACEUTICALS - DOSING FIRST SUBJECT IN TRIAL FOR PRS-060/AZD1402 BY YEAR END.  Full Article

Pieris Pharmaceuticals appoints James Geraghty as chairman of board of directors
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Pieris Pharmaceuticals Inc :Pieris Pharmaceuticals appoints James Geraghty as chairman of the board of directors.Pieris Pharmaceuticals Inc - ‍Geraghty replaces Chau Khuong, who is stepping down from board​.  Full Article

Pieris Pharmaceuticals reports Q3 loss per share $0.16
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Pieris Pharmaceuticals Inc :Pieris Pharmaceuticals reports financial results for the third quarter ended september 30, 2017, and provides corporate update.Q3 loss per share $0.16.Pieris Pharmaceuticals Inc - ‍cash and equivalents totaled $89.9 million as of September 30, 2017, compared to $29.4 million as of December 31, 2016​.  Full Article

Pieris Pharma says entered into a sales agreement with Cowen and Co
Wednesday, 5 Oct 2016 

Pieris Pharmaceuticals Inc : Under agreement co may offer, sell shares of stock, par value $0.001 per share an offering price of up to $35 million through Cowen .Says entered into a sales agreement with Cowen And Company - SEC filing.  Full Article

Pieris Pharmaceuticals files for mixed shelf of up to $100 mln- sec filnig
Friday, 3 Jun 2016 

Pieris Pharmaceuticals Inc :Files for mixed shelf of up to $100 million - sec filnig.  Full Article

Pieris Pharmaceuticals announces $16.5 mln private placement
Friday, 3 Jun 2016 

Pieris Pharmaceuticals Inc : Pieris Pharmaceuticals announces $16.5 million private placement . Private placement will consist of 8.2 million units at a price of $2.015 per unit .To use proceeds towards further development and pre-clinical, clinical work of co's proprietary anticalinâ product portfolio.  Full Article

Pieris Pharmaceuticals Q1 loss per share $0.10
Wednesday, 11 May 2016 

Pieris Pharmaceuticals Inc : Pieris pharmaceuticals reports financial results and corporate update for the first quarter ended march 31, 2016 .Q1 loss per share $0.10.  Full Article